Registry Stop Signal

autologous dendritic cells pulsed with tumor lysate antigen Vaccine

autologous dendritic cells pulsed with tumor lysate antigen Vaccine is flagged as registry stop signal because public records show a registry stop signal, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Giant Cell Glioblastoma

Mechanism: Unknown

Modality: Unknown

Sponsor: Jonsson Comprehensive Cancer Center

Scores

Risk-signal summary

Registry: 5/5

Timeline: 1/5

Recruitment burden: 3/5

Results availability: 0/5

Program risk: 4/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT03014804

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT03014804Registry Stop Signal (WITHDRAWN)stale_update_signalLow Signalrare_population_signal | strict_eligibility_signal | complex_intervention_signal